70 related articles for article (PubMed ID: 2496710)
1. The effect of interferon on cells persistently infected with HIV.
Crespi M
AIDS; 1989 Jan; 3(1):33-6. PubMed ID: 2496710
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
[TBL] [Abstract][Full Text] [Related]
3. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
Agy MB; Acker RL; Sherbert CH; Katze MG
Virology; 1995 Dec; 214(2):379-86. PubMed ID: 8553538
[TBL] [Abstract][Full Text] [Related]
4. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
Korth MJ; Taylor MD; Katze MG
Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
[TBL] [Abstract][Full Text] [Related]
5. A selective defect of IFN-gamma- but not of IFN-alpha-induced JAK/STAT pathway in a subset of U937 clones prevents the antiretroviral effect of IFN-gamma against HIV-1.
Bovolenta C; Lorini AL; Mantelli B; Camorali L; Novelli F; Biswas P; Poli G
J Immunol; 1999 Jan; 162(1):323-30. PubMed ID: 9886402
[TBL] [Abstract][Full Text] [Related]
6. Effect of interferon on Vero cells persistently infected with Sendai virus compared to Vero cells persistently infected with SSPE virus.
Crespi M; Chiu MN; Struthers JK; Schoub BD; Lyons SF
Arch Virol; 1988; 98(3-4):235-51. PubMed ID: 2831857
[TBL] [Abstract][Full Text] [Related]
7. Effects of cellular fixatives on human immunodeficiency virus production.
Cory JM; Rapp F; Ohlsson-Wilhelm BM
Cytometry; 1990; 11(5):647-51. PubMed ID: 2379457
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of IFN-gamma on HIV-1 replication in latently infected cells.
Sarol LC; Imai K; Asamitsu K; Tetsuka T; Barzaga NG; Okamoto T
Biochem Biophys Res Commun; 2002 Mar; 291(4):890-6. PubMed ID: 11866448
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the human immunodeficiency virus-1 protease and human immunodeficiency virus-1 replication by bathocuproine disulfonic acid Cu1+.
Davis DA; Branca AA; Pallenberg AJ; Marschner TM; Patt LM; Chatlynne LG; Humphrey RW; Yarchoan R; Levine RL
Arch Biochem Biophys; 1995 Sep; 322(1):127-34. PubMed ID: 7574666
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-18 enhances HIV-1 production in a human chronically-infected T cell line (H9-V).
Pugliese A; Gennero L; Vidotto V; Speranza F; Tambini R; Torre D
Cell Biochem Funct; 2002 Dec; 20(4):333-7. PubMed ID: 12415568
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block.
Rozera C; Carattoli A; De Marco A; Amici C; Giorgi C; Santoro MG
J Clin Invest; 1996 Apr; 97(8):1795-803. PubMed ID: 8621762
[TBL] [Abstract][Full Text] [Related]
12. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antisense inhibition of human immunodeficiency virus type 1 in cell cultures by DLS delivery system.
Lavigne C; Thierry AR
Biochem Biophys Res Commun; 1997 Aug; 237(3):566-71. PubMed ID: 9299405
[TBL] [Abstract][Full Text] [Related]
14. Interferon treatment inhibits the replication of simian immunodeficiency virus at an early stage: evidence for a block between attachment and reverse transcription.
Taylor MD; Korth MJ; Katze MG
Virology; 1998 Feb; 241(1):156-62. PubMed ID: 9454726
[TBL] [Abstract][Full Text] [Related]
15. Effect of D-penicillamine on the expression and propagation of the human immunodeficiency virus by H9 T-lymphoblastoid cells.
Bitterlich G; Larcher C; Sölder B; Hengster P; Myones BL; Hofbauer J; Schulz TF; Wachter H; Dierich MP
Arzneimittelforschung; 1989 Aug; 39(8):825-8. PubMed ID: 2818669
[TBL] [Abstract][Full Text] [Related]
16. Thiamine disulfide as a potent inhibitor of human immunodeficiency virus (type-1) production.
Shoji S; Furuishi K; Misumi S; Miyazaki T; Kino M; Yamataka K
Biochem Biophys Res Commun; 1994 Nov; 205(1):967-75. PubMed ID: 7999140
[TBL] [Abstract][Full Text] [Related]
17. LPS reduces HIV-1 replication in primary human macrophages partly through an endogenous production of type I interferons.
Simard S; Maurais E; Gilbert C; Tremblay MJ
Clin Immunol; 2008 May; 127(2):198-205. PubMed ID: 18295544
[TBL] [Abstract][Full Text] [Related]
18. Calmodulin antagonists inhibit human immunodeficiency virus-induced cell fusion but not virus replication.
Srinivas RV; Bernstein H; Oliver C; Compans RW
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1489-96. PubMed ID: 7888203
[TBL] [Abstract][Full Text] [Related]
19. Effect of interferon on Vero cells persistently infected with SSPE virus and lytically infected with measles virus.
Crespi M; Chiu MN; Schoub BD; Lyons SF
Arch Virol; 1986; 90(1-2):87-96. PubMed ID: 3729726
[TBL] [Abstract][Full Text] [Related]
20. Interferon-alpha treatment leads to accumulation of virus particles on the surface of cells persistently infected with the human immunodeficiency virus type 1.
Yasuda Y; Miyake S; Kato S; Kita M; Kishida T; Kimura T; Ikuta K
J Acquir Immune Defic Syndr (1988); 1990; 3(11):1046-51. PubMed ID: 2213506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
